Patient monitoring company Sibel Health, a spin-out of Northwestern University, closed a $30 million Series C equity financing round and received its seventh FDA clearance.

Sibel Health closes $30M Series C financing.

Enabled by advanced clinical-grade wearable sensors, the ANNE® One platform offers wireless monitoring of all vital signs for patients 12 years and older. This financing is timed to Sibel's newest FDA 510(k) clearance enabling alarms and alerts along with a powerful central station. "We are especially proud of the fact that our sensors are FDA-cleared under the IEEE SDC 11073 standard, which supports open and secure communication between medical devices replacing traditional proprietary networks. Interoperability is the future and our hospital partners are increasingly demanding it," notes Jong Yoon Lee, CTO and cofounder of Sibel Health. The ANNE® One platform is one of the first medical devices to receive FDA-clearance following the IEEE SDC 11073 standard. "Without interoperability of medical devices, particularly vital signs monitors like ours, we cannot capture the broader care context and realize the full potential of AI to detect patient deterioration earlier," adds Steve Xu MD